Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Simulations Plus, Inc. - Common Stock (NQ:SLP)

15.78 -0.13 (-0.85%)
Streaming Delayed Price Updated: 12:28 PM EDT, Jun 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 65,743
Open 15.94
Bid (Size) 15.72 (200)
Ask (Size) 15.84 (400)
Prev. Close 15.91
Today's Range 15.73 - 16.67
52wk Range 11.09 - 28.65
Shares Outstanding 20,206,550
Dividend Yield 1.52%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Simulations Plus, Inc. (SLP) Securities Fraud Investigation: Johnson Fistel Investigates Investor Losses Following Revenue Outlook Revision, Impairment Charge, and Auditor Dispute
From Johnson Fistel, PLLP
Via Business Wire
News headline image
Robbins LLP is Investigating Allegations that the Officers and Directors of Simulations Plus, Inc. (SLP) Violated Securities Laws and Breached Fiduciary Duties to Shareholders
From Robbins LLP
Via Business Wire

Performance

YTD
-12.9%
-12.9%
1 Month
+7.4%
+7.4%
3 Month
+26.9%
+26.9%
6 Month
-19.3%
-19.3%
1 Year
-42.5%
-42.5%

More News

Read More
News headline image
Simulations Plus to Participate in the 23rd Annual Craig-Hallum Institutional Investor Conference
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus and NVIDIA Collaborate to Scale GPU-Accelerated, AI-Assisted Modeling Workflows
From Simulations Plus, Inc.
Via Business Wire
Simulations Plus Inc (NASDAQ:SLP) Meets Q1 Revenue Target Amid Software Segment Decline ↗
Via Chartmill
News headline image
Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School
From Simulations Plus, Inc.
Via Business Wire
News headline image
Why Simulations Plus Stock Inched Higher Today ↗
Via The Motley Fool
News headline image
Simulations Plus (SLP) Q2 2026 Earnings Transcript ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Discover the top movers in Friday's pre-market session. ↗
Via Chartmill
Stay updated with the stocks that are on the move in today's after-hours session. ↗
Via Chartmill
News headline image
Simulations Plus Reports Second Quarter Fiscal 2026 Financial Results
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Announces Second Quarter Fiscal Year 2026 Earnings and Conference Call Date
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Announces Strategic Collaboration Programs for AI-Enabled Modeling
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Convenes Industry and Regulatory Leaders to Define Responsible AI in MIDD
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Announces Extensions of U.S. FDA and NIEHS Research Collaborations
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus to Participate in Upcoming Investor Conferences
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Highlights Platform Innovation and Strategic Direction at 2026 Investor Day
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus (SLP) Q1 2026 Earnings Transcript ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Simulations Plus Reports First Quarter Fiscal 2026 Financial Results
From Simulations Plus, Inc.
Via Business Wire
News headline image
Certara’s Volatility: From a 23% Earnings Plunge to a $3 Million Institutional Vote of Confidence
Via MarketMinute
Topics Earnings
News headline image
Simulations Plus to Host Virtual Investor Day Highlighting Strategy for the Next Era of Model-Informed Drug Development
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Announces First Quarter Fiscal Year 2026 Earnings and Conference Call Date
From Simulations Plus, Inc.
Via Business Wire
News headline image
Simulations Plus Positioned to Capitalize on FDA’s Streamlined Nonclinical Safety Guidance with Advanced Mechanistic and Model-Informed Solutions
From Simulations Plus, Inc.
Via Business Wire
News headline image
Why Shares of Simulations Plus Soared This Week ↗
Via The Motley Fool
Topics Artificial Intelligence

Frequently Asked Questions

Is Simulations Plus, Inc. - Common Stock publicly traded?
Yes, Simulations Plus, Inc. - Common Stock is publicly traded.
What exchange does Simulations Plus, Inc. - Common Stock trade on?
Simulations Plus, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Simulations Plus, Inc. - Common Stock?
The ticker symbol for Simulations Plus, Inc. - Common Stock is SLP on the Nasdaq Stock Market
What is the current price of Simulations Plus, Inc. - Common Stock?
The current price of Simulations Plus, Inc. - Common Stock is 15.78
When was Simulations Plus, Inc. - Common Stock last traded?
The last trade of Simulations Plus, Inc. - Common Stock was at 06/09/26 12:28 PM ET
What is the market capitalization of Simulations Plus, Inc. - Common Stock?
The market capitalization of Simulations Plus, Inc. - Common Stock is 318.76M
How many shares of Simulations Plus, Inc. - Common Stock are outstanding?
Simulations Plus, Inc. - Common Stock has 319M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.